Delivery Order 36C25222D0035-36C25222N0374

Award Date 4/18/22
Potential Completion Date 9/30/22
Potential Value $72K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Cepheid has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The $457,444.25 contract calls for Cepheid to provide MRSA reagents, test kits, service for a six month period to support clinical diagnostic programs. As the original equipment manufacturer and a leading provider of molecular diagnostic solutions for infectious diseases, Cepheid is well...
Cepheid has been awarded a $653,649.60 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide Cepheid Reagent Xpert MRSA, Flu, and COVID Test Kits. The contract has no set-aside designation. Performance will occur in Sunnyvale, California and services are to be completed by January 31, 2025. As the sole awardee, Cepheid will deliver their diagnostic test kits to aid the VA network in pathogen...
Cepheid has been awarded a $35,124 firm fixed price delivery order against its existing Blanket Purchase Agreement with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. The modification adds Contract Line Item Numbers 3056 through 3059 and 4056 through 4059 to supply additional molecular diagnostic goods and services in support of the agency's clinical testing programs. As the prime contractor and original equipment manufacturer, Cepheid...
Cepheid has been awarded a $127,498.64 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 for Cepheid reagents and supplies. As the prime contractor, Cepheid will provide its line of molecular diagnostic products to support testing programs at VA medical facilities located in San Antonio, Texas. Cepheid manufactures diagnostic testing platforms, consumables, and services for infectious diseases...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 12 of the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $50,542.60, is for MRSA CPRR testing and related services, with a period of performance through September 30, 2025. Cepheid is the prime contractor and original equipment manufacturer, providing the VA with its molecular diagnostic systems, reagents,...
Cepheid was awarded a $103,294.67 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide reagent and consumable supplies. The contract has a period of performance through November 21, 2022 to deliver the requested products and services to the agency location in Dallas, Texas. No set-aside provisions were applied to this award made to Cepheid as the prime contractor to support the mission...
Cepheid was awarded a $210,240.74 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The contract calls for Cepheid to provide interim VISN 2 Downstate PCR/MRSA testing through January 6, 2020 at a location in Sunnyvale, California. No set-aside designation was applied to this award to supply polymerase chain reaction and methicillin-resistant...
Cepheid, a subsidiary of Danaher Corporation, has been awarded a $541,284 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA VHA VISN 8) to provide cost per test polymerase chain reaction (PCR) microbiology molecular testing services. The one-year contract, with a period of performance from October 1, 2020 through September 30, 2021, will support VA VHA VISN 8's molecular diagnostics testing programs...
Cepheid has been awarded a $37,730.70 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide SARS COVID reagents. The place of performance is Sunnyvale, California and the completion date is September 30, 2023. No set-aside designation was used for this contract. As a manufacturer of molecular diagnostic solutions, Cepheid will supply the reagents to support the VA's clinical diagnostic testing...
The Department of Veterans Affairs (VA) awarded a $70,467.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for MRSA CPRR testing and services, with a performance period through September 30, 2024. Cepheid is the prime contractor and original equipment manufacturer, providing diagnostic testing equipment, reagents, consumables, and associated...
  • 36C25222D0035
    Indefinite Delivery Contract
  • 36C25222D0035-36C25222N0374
    Delivery Order

Cepheid has been awarded a $72,056 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide MRSA reagents, test kits, and service in Milwaukee, Wisconsin for a six-month period concluding September 30, 2022. The contract has no set-aside designation and calls for Cepheid to deliver products and services supporting the detection and treatment of Methicillin-resistant Staphylococcus aureus infections at VA medical facilities in the local area through the end of the fiscal year.

Generated 1/2/24, 11:19 AM